Genmab — November 2022
-
ESMO I-O 175P - Safety and preliminary efficacy of GEN1042 (DuoBody-CD40x4-1BB) combination therapy in patients with advanced solid tumors https://cslide.ctimeetingtech.com/immuno22hybrid/attendee/confcal/presentation/list?q=gen1042
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
ja $ kursen bevæger sig jo hele tiden. Så afhængig af tidspunkt har i begge ret. Bikube dog tættest på da jeg kiggede, men hvad. 3.320 eller 3.326 eller ? Det er f….. fine kurser